Measuring risk in end-stage renal disease: is N-terminal pro brain natriuretic peptide a useful marker? (Q30443131)

21 June 2017

title

Measuring risk in end-stage renal disease: is N-terminal pro brain natriuretic peptide a useful marker? (English)

1 reference

brain natriuretic peptide

21 June 2017

main subject

0 references

1 reference

Rosner MH

1

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

21 June 2017

1 reference

21 June 2017

volume

71

1 reference

21 June 2017

issue

6

1 reference

21 June 2017

page(s)

481-483

1 reference

Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective.

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002140

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.KI.5002140

1 reference

7 January 2021

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002140

7 January 2021

B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002140

7 January 2021

B-type natriuretic peptide and renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002140

7 January 2021

Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002140

7 January 2021

N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002140

7 January 2021

Natriuretic peptides in ESRD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002140

7 January 2021

Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002140

7 January 2021

The prognostic role of brain natriuretic peptides in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002140

7 January 2021

Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002140

7 January 2021

Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002140

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5002140

1 reference

Dimensions Publication ID

21 June 2017

1001961088

0 references

1 reference